ABSTRACT
An increased number of fungal pathogens are arising as a result of novel therapies in the field of oncology and transplantation. Candida spp. constitutes the fourth most common cause of nosocomial bloodstream infection (1).Candida albicans is by far themost common cause of candidemia, however, emerging antifungal resistance in non-albicans species has become a common problem in high-risk population. Parallel to the emergence of non-albicans’ Candida infections, increasingly recognized pathogenic yeasts have emerged as a cause of invasive infections, which include Trichosporon species, Malassezia species, Hansenula anomala, andWangiella dermatitidis.
